Important ADME & Drug-Drug Interaction Considerations for Successful Drug Development
Nov. 11, 2021 • Webinar 2pm ETRegister
In vitro ADME and drug-drug interaction (DDI) investigations are early activities in the drug development process that are critical for framing downstream decision making.
This webinar will provide high-level insights related to regulatory drivers, investigatory objectives, and generally relevant concerns for such studies. Participants will gain insight about the critical need and utility for in vitro ADME and DDI investigations related to drug development.
In addition, the webinar will cover regulatory expectations and points of interest for enabling successful achievement of investigatory goals. The webinar will also include the following highlights:
- Why run these studies?
- Predominant types of in vitro ADME & DDI studies
- When to conduct these studies
- Areas of concern related to proper design and interpretation
- And other critical tips for successful drug development